|
US4078060A
(en)
*
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
|
US4434228A
(en)
*
|
1982-04-20 |
1984-02-28 |
Genex Corporation |
Immobilization of biological materials in condensed polyalkyleneimine polymers
|
|
US4816568A
(en)
*
|
1986-05-16 |
1989-03-28 |
International Minerals & Chemical Corp. |
Stabilization of growth hormones
|
|
JPS63287730A
(ja)
|
1987-05-20 |
1988-11-24 |
Nippon Shokubai Kagaku Kogyo Co Ltd |
経皮吸収促進剤およびこれを含有してなる皮膚外用剤
|
|
US5252713A
(en)
*
|
1988-09-23 |
1993-10-12 |
Neorx Corporation |
Polymeric carriers for non-covalent drug conjugation
|
|
US5420105A
(en)
*
|
1988-09-23 |
1995-05-30 |
Gustavson; Linda M. |
Polymeric carriers for non-covalent drug conjugation
|
|
US5744166A
(en)
*
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US6126945A
(en)
*
|
1989-10-03 |
2000-10-03 |
Pharmacia Ab |
Tumor killing effects of enterotoxins, superantigens, and related compounds
|
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
|
JPH06501938A
(ja)
|
1990-10-24 |
1994-03-03 |
アレリックス バイオファーマシューティカルズ アイエヌシー． |
ペプチドよりなるｈｉｖ複製阻害剤
|
|
GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US5607691A
(en)
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
EP0903408A3
(en)
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
US5260082A
(en)
|
1992-09-16 |
1993-11-09 |
Kraft General Foods, Inc. |
Baked goods, doughs or batters, dry mixes and methods for producing thereof
|
|
US5877278A
(en)
*
|
1992-09-24 |
1999-03-02 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
|
US6986893B2
(en)
*
|
1993-12-28 |
2006-01-17 |
Allergan, Inc. |
Method for treating a mucus secretion
|
|
US6974578B1
(en)
*
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
EP1488803B1
(en)
|
1993-12-28 |
2008-03-26 |
Allergan, Inc. |
Neurotoxic component of botulinum toxins for treating cervical dystonia
|
|
US5766605A
(en)
*
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
|
EP1086702B1
(en)
*
|
1994-05-09 |
2005-04-13 |
BINDER, William J. |
Presynaptic neurotoxins for treatment of migraine headache
|
|
NO180167C
(no)
*
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
|
US6232295B1
(en)
|
1994-10-12 |
2001-05-15 |
Jon Faiz Kayyem |
Cell-specific contrast agent and gene delivery vehicles
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5756468A
(en)
*
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
GB9508204D0
(en)
*
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
GB9600272D0
(en)
|
1996-01-06 |
1996-03-06 |
Univ Nottingham |
Polymers
|
|
WO1997040854A2
(en)
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
|
US6444209B1
(en)
*
|
1996-10-28 |
2002-09-03 |
Wisconsin Alumni Research Foundation |
Hybrid botulinal neurotoxins
|
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
|
FR2755976B1
(fr)
|
1996-11-15 |
1999-01-15 |
Idm Immuno Designed Molecules |
Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
|
|
US6228161B1
(en)
|
1996-12-30 |
2001-05-08 |
Minerals Technologies Inc. |
Use of calcium carbonate in an acidic aqueous media
|
|
FR2759298B1
(fr)
|
1997-02-10 |
1999-04-09 |
Rhone Poulenc Rorer Sa |
Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
|
|
CA2291074C
(en)
*
|
1997-05-21 |
2008-04-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composition and method for enhancing transport across biological membranes
|
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
WO1999024596A1
(en)
|
1997-11-12 |
1999-05-20 |
Valentis, Inc. |
Expression plasmids for multiepitope nucleic acid-based vaccines
|
|
US5985434A
(en)
*
|
1997-11-25 |
1999-11-16 |
Kimberly-Clark Worldwide, Inc. |
Absorbent foam
|
|
WO1999029721A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
WO1999042091A2
(en)
*
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
|
US6011646A
(en)
|
1998-02-20 |
2000-01-04 |
The Regents Of The Unviersity Of California |
Method to adjust multilayer film stress induced deformation of optics
|
|
WO1999043350A1
(en)
|
1998-02-25 |
1999-09-02 |
Iomai Corporation |
Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
|
|
WO1999055332A1
(en)
|
1998-04-27 |
1999-11-04 |
Fujisawa Pharmaceutical Co., Ltd. |
Medicinal compositions
|
|
US6261679B1
(en)
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
|
TR200100254T2
(tr)
*
|
1998-07-13 |
2001-06-21 |
Expression Genetics, Inc. |
Eriyebilir ve bakterilerle ayrışabilir bir gen iletim taşıyıcısı olarak poly-l-lysine benzeri bir poliyester.
|
|
US6280937B1
(en)
*
|
1998-08-14 |
2001-08-28 |
Rigel Pharmaceuticals, Inc. |
Shuttle vectors
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
US6958147B1
(en)
*
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
WO2000024419A1
(en)
|
1998-10-27 |
2000-05-04 |
Mayo Foundation For Medical Education And Research |
Methods for enhancing wound healing
|
|
JP2002532388A
(ja)
|
1998-12-02 |
2002-10-02 |
イ・デ・エム・イミュノ−デジネ・モレキュル |
生物学的分子を細胞中へ移入させやすくする新規なオリゴマーコンジュゲート
|
|
EP1137664A2
(en)
|
1998-12-10 |
2001-10-04 |
Washington University |
Protein transduction system and methods of use thereof
|
|
US6627632B2
(en)
*
|
1998-12-14 |
2003-09-30 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
|
CN1320880C
(zh)
|
1998-12-23 |
2007-06-13 |
伊迪亚股份公司 |
改进的体内局部无创伤用制剂
|
|
US7056656B1
(en)
*
|
1999-01-25 |
2006-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
|
|
ES2160485B1
(es)
|
1999-04-23 |
2002-05-16 |
Lipotec Sa |
Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
|
|
US7442764B2
(en)
*
|
1999-06-07 |
2008-10-28 |
Mirns Bio Corporation |
Reversible modification of amine-containing compounds
|
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US20030236214A1
(en)
|
1999-06-09 |
2003-12-25 |
Wolff Jon A. |
Charge reversal of polyion complexes and treatment of peripheral occlusive disease
|
|
US7008924B1
(en)
*
|
1999-07-21 |
2006-03-07 |
Amgen, Inc. |
VGF fusion polypeptides
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
MXPA02001857A
(es)
*
|
1999-08-24 |
2003-07-14 |
Cellgate Inc |
Composiciones y metodos para incrementar la entrega de drogas a traves y dentro de tejidos epiteliales.
|
|
US7229961B2
(en)
*
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US20030104622A1
(en)
*
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
US6544548B1
(en)
*
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
US6458763B1
(en)
*
|
1999-09-17 |
2002-10-01 |
Depuy Orthopeadics |
Bone sialoprotein-based compositions for enhancing connective tissue repair
|
|
US6773928B1
(en)
*
|
1999-09-22 |
2004-08-10 |
The United States Of America As Represented By The Secretary Of The Army |
Compositions and methods for enhancing bioassay performance
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6844324B1
(en)
*
|
1999-11-12 |
2005-01-18 |
Massachusetts Institute Of Technology |
Modular peptide mediated intracellular delivery system and uses therefore
|
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
|
US20040109871A1
(en)
*
|
2000-01-06 |
2004-06-10 |
Pascual David W. |
M cell directed vaccines
|
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US7780967B2
(en)
*
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
JP2003522154A
(ja)
*
|
2000-02-08 |
2003-07-22 |
アラーガン、インコーポレイテッド |
ボツリヌス毒素医薬組成物
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT411041B
(de)
*
|
2000-05-18 |
2003-09-25 |
Josef Lindenberg |
Verfahren zur herstellung von glasfliesen, glasbordüren, glasdekorpaneelen oder dgl.
|
|
US6670322B2
(en)
*
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US6306403B1
(en)
*
|
2000-06-14 |
2001-10-23 |
Allergan Sales, Inc. |
Method for treating parkinson's disease with a botulinum toxin
|
|
US7491799B2
(en)
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
JP5610659B2
(ja)
*
|
2000-07-21 |
2014-10-22 |
ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
多成分生物学的輸送システム
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US20030219462A1
(en)
*
|
2000-07-21 |
2003-11-27 |
Allergan Sales, Inc |
Clostridial neurotoxin compositions and modified clostridial neurotoxins
|
|
US20030215412A1
(en)
|
2000-07-21 |
2003-11-20 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
JP2002072267A
(ja)
*
|
2000-08-25 |
2002-03-12 |
National Institute For Materials Science |
光機能素子、該素子用単結晶基板、およびその使用方法
|
|
US6696038B1
(en)
*
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US6831059B2
(en)
|
2000-10-20 |
2004-12-14 |
Allergan, Inc. |
Compositions and methods for treating gonadotrophin related illnesses
|
|
US20020127247A1
(en)
|
2000-11-17 |
2002-09-12 |
Allergen Sales, Inc. |
Modified clostridial neurotoxins with altered biological persistence
|
|
US20020086036A1
(en)
*
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
|
US7255865B2
(en)
*
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
MXPA03007358A
(es)
|
2001-02-16 |
2004-12-13 |
Cellgate Inc |
Transportadores que contienen porciones de arginina separadas.
|
|
AU2002250293B2
(en)
*
|
2001-03-09 |
2007-10-11 |
Arnason, Barry G. Mr |
Polymeric immunoglobulin fusion proteins that target low-affinity FCGammaReceptors
|
|
CA2367636C
(en)
*
|
2001-04-12 |
2010-05-04 |
Lisa Mckerracher |
Fusion proteins
|
|
WO2003011333A1
(en)
|
2001-07-27 |
2003-02-13 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Botulinum toxin in the treatment or prevention of acne
|
|
DE10146647A1
(de)
*
|
2001-09-21 |
2003-04-24 |
Marc Heckmann |
Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
|
|
WO2003041128A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Pharmacia Corporation |
Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
|
|
US7060498B1
(en)
*
|
2001-11-28 |
2006-06-13 |
Genta Salus Llc |
Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
|
|
CA2469336C
(en)
*
|
2001-12-11 |
2013-06-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Guanidinium transport reagents and conjugates
|
|
US20030113349A1
(en)
*
|
2001-12-18 |
2003-06-19 |
Coleman William P. |
Topically applied clostridium botulinum toxin compositions and treatment methods
|
|
AU2002360712A1
(en)
*
|
2001-12-21 |
2003-07-30 |
The Trustees Of Columbia University In The City Of New York |
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
|
|
US20030147958A1
(en)
*
|
2002-01-29 |
2003-08-07 |
Cheol-Hee Ahn |
Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
|
|
AU2003216389A1
(en)
|
2002-02-21 |
2003-09-09 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
EP1572941A4
(en)
*
|
2002-02-26 |
2009-03-18 |
Maxygen Inc |
NEW FLAVIVIRUS ANTIGENES
|
|
CA2476589C
(en)
*
|
2002-02-27 |
2014-02-25 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
US6688311B2
(en)
*
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
CN1383811A
(zh)
*
|
2002-05-16 |
2002-12-11 |
卢伟成 |
一种除皱化妆品及其制作工艺
|
|
US7459164B2
(en)
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
|
NZ537120A
(en)
|
2002-05-31 |
2008-07-31 |
Univ Jefferson |
Compositions and methods for transepithelial molecular transport
|
|
US20040009180A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US20040242518A1
(en)
*
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US9265725B2
(en)
*
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US7071167B2
(en)
*
|
2002-11-13 |
2006-07-04 |
L'oreal |
Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
|
|
AU2002350719A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
US6866856B2
(en)
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
US7482016B2
(en)
|
2003-03-19 |
2009-01-27 |
The J. David Gladstone Institutes |
Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides
|
|
US20040192754A1
(en)
|
2003-03-24 |
2004-09-30 |
Shapira Nathan Andrew |
Methods for treating idiopathic hyperhidrosis and associated conditions
|
|
US20040247623A1
(en)
*
|
2003-03-24 |
2004-12-09 |
Roger Cady |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
WO2005030119A2
(en)
|
2003-04-11 |
2005-04-07 |
Allergan, Inc. |
Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
|
US20050074425A1
(en)
*
|
2003-07-02 |
2005-04-07 |
Polycord, Inc. |
Method for delivering polymerized therapeutic agent compositions and compositions thereof
|
|
US7883720B2
(en)
*
|
2003-07-09 |
2011-02-08 |
Wisconsin Alumni Research Foundation |
Charge-dynamic polymers and delivery of anionic compounds
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
US8871224B2
(en)
*
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
|
US9211248B2
(en)
*
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
SG150570A1
(en)
*
|
2004-03-03 |
2009-03-30 |
Revance Therapeutics Inc |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
CA2558408C
(en)
*
|
2004-03-03 |
2014-11-18 |
Essentia Biosystems, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20060040882A1
(en)
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
KR100852824B1
(ko)
*
|
2004-07-26 |
2008-08-18 |
메르츠 파마 게엠베하 운트 코. 카가아 |
보툴리눔 신경독소를 포함하는 치료 조성물
|
|
US20060024331A1
(en)
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
|
JP2006067889A
(ja)
*
|
2004-09-01 |
2006-03-16 |
Japan Science & Technology Agency |
Ｐｅｏと二本鎖核酸のコンジュゲート
|
|
WO2006094263A2
(en)
*
|
2005-03-03 |
2006-09-08 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
SG160358A1
(en)
*
|
2005-03-03 |
2010-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of an oligopeptide
|
|
JP2008532522A
(ja)
*
|
2005-03-08 |
2008-08-21 |
モレキュラー プローブス， インコーポレイテッド |
ナノ構造を用いた細胞膜電位差のモニターおよび操作
|
|
DE602006017207D1
(de)
*
|
2005-05-11 |
2010-11-11 |
Eth Zuerich |
Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
|
|
DE102005039189B4
(de)
|
2005-08-18 |
2010-09-09 |
Siemens Ag |
Bildauswertungsverfahren für zweidimensionale Projektionsbilder und hiermit korrespondierende Gegenstände
|
|
US8168206B1
(en)
*
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
US8137677B2
(en)
*
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
NZ568216A
(en)
*
|
2005-11-17 |
2012-09-28 |
Revance Therapeutics Inc |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
|
US9486408B2
(en)
*
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US20100021502A1
(en)
|
2006-12-28 |
2010-01-28 |
Waugh Jacob M |
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
|
|
AU2007340162B2
(en)
*
|
2006-12-29 |
2013-08-01 |
Revance Therapeutics, Inc. |
Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
|
|
WO2008082885A2
(en)
*
|
2006-12-29 |
2008-07-10 |
Revance Therapeutics, Inc. |
Transport molecules using reverse sequence hiv-tat polypeptides
|
|
AU2009215341B2
(en)
*
|
2008-02-20 |
2015-03-26 |
Glaxosmithkline Biologicals S.A. |
Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
|
|
US20170361130A9
(en)
*
|
2008-05-23 |
2017-12-21 |
Pankaj Modi |
Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
|
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
|
KR20110059861A
(ko)
*
|
2008-09-29 |
2011-06-07 |
파나소닉 주식회사 |
정보 기록 매체, 기록 방법 및 재생 방법
|
|
RU2011125776A
(ru)
*
|
2008-12-31 |
2013-02-10 |
Реванс Терапьютикс, Инк. |
Композиции и способы лечения гиперпигментации
|
|
ES2669020T3
(es)
*
|
2008-12-31 |
2018-05-23 |
Revance Therapeutics, Inc. |
Formulaciones inyectables de toxina botulínica
|
|
WO2010114828A1
(en)
*
|
2009-04-01 |
2010-10-07 |
Revance Therapeutics, Inc. |
Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
|
|
JP6043627B2
(ja)
*
|
2009-06-25 |
2016-12-14 |
ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
アルブミン非含有ボツリヌス毒素製剤
|
|
US9737500B2
(en)
*
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9504664B2
(en)
*
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
ES2641068T3
(es)
*
|
2011-01-07 |
2017-11-07 |
Revance Therapeutics, Inc. |
Composición tópica que comprende una toxina botulínica y un colorante
|
|
US8697090B2
(en)
*
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
|
US8586020B2
(en)
*
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
CA2848740A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Mingxing Wang |
Amphiphilic cationic polymers for the delivery of therapeutic agents
|
|
JP2015501844A
(ja)
*
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
AU2013211903A1
(en)
*
|
2012-01-27 |
2014-08-21 |
Revance Therapeutics, Inc. |
Methods and assessment scales for measuring wrinkle severity
|
|
CN104602703A
(zh)
*
|
2012-03-22 |
2015-05-06 |
雷文斯治疗公司 |
使用局部化学性去神经支配剂处理皱纹的方法
|
|
US9541558B2
(en)
*
|
2012-09-05 |
2017-01-10 |
California Institute Of Technology |
Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses
|
|
MX370929B
(es)
*
|
2012-10-28 |
2020-01-08 |
Revance Therapeutics Inc |
Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
|
|
US20150259283A1
(en)
*
|
2014-03-13 |
2015-09-17 |
Brickell Biotech, Inc. |
Formulation for soft anticholinergic analogs
|
|
US10485855B2
(en)
*
|
2014-05-01 |
2019-11-26 |
Anterios, Inc. |
Demonstrable efficacy across or within patient populations
|
|
RU2694820C9
(ru)
*
|
2014-12-23 |
2019-08-12 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Контейнер, предварительно заполненный ботулиновым токсином
|
|
JP6813492B2
(ja)
*
|
2015-02-03 |
2021-01-13 |
メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン |
ボツリヌス毒素充填済み容器
|
|
RU2018119765A
(ru)
*
|
2015-10-29 |
2019-12-02 |
Реванс Терапьютикс, Инк. |
Инъекционные препараты на основе ботулотоксина и способы их применения, обеспечивающие длительное терапевтическое и косметического действие
|
|
KR20190022476A
(ko)
*
|
2016-04-12 |
2019-03-06 |
일루스트리스 파마슈티컬즈 인코포레이티드 |
화합물의 국소 도포용 조성물
|
|
WO2019075263A2
(en)
*
|
2017-10-11 |
2019-04-18 |
Illustris Pharmaceuticals, Inc. |
METHODS AND COMPOSITIONS WITH TOPICAL ADMINISTRATION
|
|
CN116764087A
(zh)
*
|
2018-08-15 |
2023-09-19 |
阿勒根公司 |
具有活性成分的微针阵列
|